Market closed
Biomerica/$BMRA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Biomerica
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
Ticker
$BMRA
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
-
Website
Biomerica Metrics
BasicAdvanced
$10M
-
-$0.33
-1.05
-
Price and volume
Market cap
$10M
Beta
-1.05
52-week high
$0.83
52-week low
$0.46
Average daily volume
171K
Financial strength
Current ratio
3.169
Quick ratio
1.971
Long term debt to equity
5.553
Total debt to equity
12.241
Management effectiveness
Return on assets (TTM)
-38.54%
Return on equity (TTM)
-77.33%
Valuation
Price to revenue (TTM)
1.675
Price to book
1.98
Price to tangible book (TTM)
2.08
Price to free cash flow (TTM)
-1.849
Growth
Revenue change (TTM)
1.40%
Earnings per share change (TTM)
-13.10%
3-year revenue growth (CAGR)
-19.24%
3-year earnings per share growth (CAGR)
-14.38%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Biomerica stock?
Biomerica (BMRA) has a market cap of $10M as of April 16, 2025.
What is the P/E ratio for Biomerica stock?
The price to earnings (P/E) ratio for Biomerica (BMRA) stock is 0 as of April 16, 2025.
Does Biomerica stock pay dividends?
No, Biomerica (BMRA) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Biomerica dividend payment date?
Biomerica (BMRA) stock does not pay dividends to its shareholders.
What is the beta indicator for Biomerica?
Biomerica (BMRA) has a beta rating of -1.05. This means that it has an inverse relation to market volatility.